연구동향 분석
박사

Effect of morphine on OGFR in relation with OGF-OGFR axis

김지연 2015년

논문상세정보
인용/피인용
' Effect of morphine on OGFR in relation with OGF-OGFR axis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • lung cancer
  • morphine
  • opioid growth factor
  • opioid growth factor receptor
  • proliferation
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
355 0

0.0%

' Effect of morphine on OGFR in relation with OGF-OGFR axis' 의 참고문헌

  • Zagon, I.S., et al., Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor. Int J Oncol, 2008. 33(2): p. 317-23.
  • Zagon, I.S., Y. Wu, and P.J. McLaughlin, Opioid growth factor and organ development in rat and human embryos. Brain Res, 1999. 839(2): p. 313-22.
  • Zagon, I.S., S.D. Hytrek, and P.J. McLaughlin, Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am J Physiol, 1996. 271(3 Pt 2): p. R511-8.
  • Zagon, I.S., R.N. Donahue, and P.J. McLaughlin, Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regul Integr Comp Physiol, 2009. 297(4): p. R1154-61.
  • Zagon, I.S., M.F. Verderame, and P.J. McLaughlin, The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev, 2002. 38(3): p. 351-76.
  • Sueoka, E., et al., Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun, 1998. 252(3): p. 566-70.
  • Snyder, G.L. and S. Greenberg, Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth, 2010. 105(2): p. 106-15.
  • Singleton, P.A., et al., Increased mu-opioid receptor expression in metastatic lung cancer. Br J Anaesth, 2014. 113 Suppl 1: p. i103-8.
  • Scavonetto, F., et al., Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. Br J Anaesth, 2014. 113 Suppl 1: p. i95-102.
  • Sassani, J.W., I.S. Zagon, and P.J. McLaughlin, Opioid growth factor modulation of corneal epithelium: uppers and downers. Curr Eye Res, 2003. 26(5): p. 249-62.
  • Qin, Y., et al., Exogenous morphine inhibits human gastric cancer MGC- 803 cell growth by cell cycle arrest and apoptosis induction. Asian Pac J Cancer Prev, 2012. 13(4): p. 1377-82.
  • Myles, P.S., et al., Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ, 2011. 342: p. d1491.
  • McLaughlin, P.J., et al., Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck. Cancer, 2003. 97(7): p. 1701-10.
  • McLaughlin, P.J., R.J. Levin, and I.S. Zagon, Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int J Oncol, 1999. 14(5): p. 991-8.
  • McLaughlin, P.J. and I.S. Zagon, The opioid growth factor-opioid growth factor receptor axis: Homeostatic regulator of cell proliferation and its implications for health and disease. Biochem Pharmacol, 2012. 84(6): p. 746-55.
  • Mathew, B., et al., The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg, 2011. 112(3): p. 558-67.
  • Maher, D.P., et al., Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis. Br J Anaesth, 2014. 113 Suppl 1: p. i88-94.
  • Leslie, F.M., Methods used for the study of opioid receptors. Pharmacol Rev, 1987. 39(3): p. 197-249.
  • Lennon, F.E., et al., The Mu opioid receptor promotes opioid and growth factorinduced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One, 2014. 9(3): p. e91577.
  • Lennon, F.E., et al., Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology, 2012. 116(4): p. 857-67.
  • Harimaya, Y., et al., Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett, 2002. 187(1-2): p. 121-7.
  • Gach, K., et al., The role of morphine in regulation of cancer cell growth. Naunyn Schmiedebergs Arch Pharmacol, 2011. 384(3): p. 221-30.
  • Fujioka, N., et al., Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg, 2011. 113(6): p. 1353-64.
  • Fanning, J., et al., Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancer. Gynecol Oncol, 2012. 124(2): p. 319-24.
  • Exadaktylos, A.K., et al., Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology, 2006. 105(4): p. 660-4.
  • Cheng, F., et al., The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer. Cancer Res, 2007. 67(21): p. 10511-8.
  • Cheng, F., et al., The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer. Mol Cancer, 2008. 7: p. 5.
  • Cheng, F., et al., The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation. Mol Biol Cell, 2009. 20(1): p. 319-27.
  • Cata, J.P., et al., A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med, 2014. 3(4): p. 900-8.
  • Biki, B., et al., Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology, 2008. 109(2): p. 180-7.
  • Afsharimani, B., P. Cabot, and M.O. Parat, Morphine and tumor growth and metastasis. Cancer Metastasis Rev, 2011. 30(2): p. 225-38.